Teva Pharmaceutical Industries Limited

From Teva Pharmaceutical Industries's results release of 3. November 2026; its quarterly report has since been filed.

• Revenue

  Actual

  4,4B $

  -1,9 % y/y ↓
  +6,1 % q/q ↑

  Guided

  —

  No guide given

• EPS, GAAP

  Actual

  0,20 $

  -46 % y/y ↓

  Guided

  —

  No guide given

  EPS, adjusted: 0,86 $

• Operating income, GAAP

  Actual

  714M $

  -19 % y/y ↓

  Guided

  —

  No guide given

  Operating income, adjusted: 1,39B $

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.